Simon Douglas Selected Research

Alzheimer Disease (Alzheimer's Disease)

9/2009	Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
2/2009	The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.
4/2008	A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
4/2005	Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon Douglas Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 09/2009 - 04/2005
3	Dementia (Dementias) 02/2009 - 04/2005
2	Cognitive Dysfunction 04/2008 - 04/2005

Drug/Important Bio-Agent (IBA)

2	Antipsychotic Agents (Antipsychotics)IBA 02/2009 - 04/2008
1	Haloperidol (Haldol)FDA LinkGeneric 04/2008
1	Chlorpromazine (Thorazine)FDA Link 04/2008
1	Thioridazine (Mellaril)FDA LinkGeneric 04/2008
1	Trifluoperazine (Stelazine)FDA LinkGeneric 04/2008
1	Risperidone (Risperdal Consta)FDA LinkGeneric 04/2008
1	Rivastigmine (Exelon)FDA LinkGeneric 04/2005
1	Quetiapine Fumarate (Seroquel)FDA Link 04/2005

Therapy/Procedure

1	Therapeutics 09/2009
1	Drug Therapy (Chemotherapy) 09/2009